Skip to content
Oxazepam
Serax, Zaxopam (oxazepam) is a small molecule pharmaceutical. Oxazepam was first approved as Serax on 1982-01-01. It is used to treat alcohol withdrawal delirium, anxiety disorders, and partial epilepsies in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
chemically-induced disordersD064419
mental disordersD001523
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxazepam
Tradename
Company
Number
Date
Products
SERAXAlpharmaN-015539 DISCN1982-01-01
4 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
oxazepamANDA2022-08-11
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
alcohol withdrawal deliriumEFO_1000800D000430—
anxiety disordersEFO_0006788D001008F41.1
partial epilepsiesEFO_0004263D004828—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N05: Psycholeptics
— N05B: Anxiolytics
— N05BA: Benzodiazepine derivative anxiolytics
— N05BA04: Oxazepam
HCPCS
No data
Clinical
Clinical Trials
19 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv wasting syndromeD019247EFO_0007312———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
BurnsD002056T30.0—22——2
NeoplasmsD009369C80——1——1
Body weight changesD001836——1——1
Pressure ulcerD003668L89——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Turner syndromeD014424Orphanet_881Q96—2———2
Wounds and injuriesD014947T14.8—1———1
AnemiaD000740EFO_0004272D64.9—1———1
Iron deficienciesD000090463E61.1—1———1
Congenital heart defectsD006330HP_0001627Q24.911———1
Hypoplastic left heart syndromeD018636Q23.411———1
Klinefelter syndromeD007713EFO_1001006Q98.0—1———1
DwarfismD004392E34.31—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Biological availabilityD0016821————1
MalnutritionD044342EFO_0008572E40-E461————1
Fanconi anemiaD005199Orphanet_84D61.091————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Muscular dystrophiesD009136EFO_0000757G71.0————11
Rotator cuff injuriesD000070636M75.1————11
Spinal cord injuriesD013119EFO_1001919————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXAZEPAM
INNoxazepam
Description
Oxazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5. It has a role as a xenobiotic, an environmental contaminant and an anxiolytic drug. It is a 1,4-benzodiazepinone and an organochlorine compound.
Classification
Small molecule
Drug classantianxiety agents (diazepam type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
Identifiers
PDB—
CAS-ID604-75-1
RxCUI7781
ChEMBL IDCHEMBL568
ChEBI ID7823
PubChem CID4616
DrugBankDB00842
UNII ID6GOW6DWN2A (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,120 documents
View more details
Safety
Black-box Warning
Black-box warning for: Oxazepam
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
144 adverse events reported
View more details